Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2023

5-Year COAPT Outcomes With MitraClip in FMR

Presenter: Gregg Stone

March 22, 2023

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2022

ALIVE IDE Pivotal Trial Update

Presenter: Gregg Stone

February 02, 2022

Presentation THT 2022

PROTECT IV: A Transcatheter Heart Failure Therapy Trial

Presenter: Gregg Stone

February 01, 2022

Presentation THT 2022

Special Challenges of Heart Failure Device Trials

Presenter: Gregg Stone

February 01, 2022

Advertisement

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

5-Year COAPT Outcomes With MitraClip in FMR

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

ALIVE IDE Pivotal Trial Update

PROTECT IV: A Transcatheter Heart Failure Therapy Trial

Special Challenges of Heart Failure Device Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content